NASDAQ:NVCR (NovoCure)
About NVCR
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
NovoCure (NASDAQ: NVCR) Latest News
![Bronze bull and bear figurines](https://www.fool.co.uk/wp-content/uploads/2022/11/Bull-vs-bear-400x225.jpg)